Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

• Monocyte and macrophage phenotype and function in sepsis acute hepatic failure and chronic liver disease.

  View Trial

• PROFILE

  PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE) trial

  View Trial

• The consequences of SDHA fusion gene on tumorigenesis and tumour metabolism in well differentiated retroperitoneal liposarcoma

  View Trial

• RAPPER

  Radiogenomics: Assessment of polymorphisms for predicting the effects of radiotherapy

  View Trial

• STRIKE

  STRIKE: Stratification for risk of progression in scleroderma

  View Trial

• M14-533

  A Phase 3 Multicenter Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis (UC)

  View Trial

• A comparative qualitative study of patients’ experiences of cancer diagnosis in England Denmark and Sweden: can comparative analysis of patients’ narratives help us identify how to improve cancer services?

  View Trial

• M14-234

  A Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis

  View Trial

• IBD Bioresource

  The Inflammatory Bowel Disease BioResource: Progressing from Genetics to Function and Clinical Translation in Crohn’s Disease & Ulcerative Colitis

  View Trial

• A randomised double-blind placebo controlled study in COPD patients with and without a confirmed respiratory virus infection assessing anti-viral biomarker responses of inhaled SNG001 compared to placebo.

  View Trial